Merck uncomfortably numb after settlement

Merck, the manufacturer of painkiller Vioxx, has settled deceptive advertising charges for $58 million and agreed to submit all new television com­mercials for its drugs to the Food and Drug Administration for review for the next seven years. The agency had challenged Merck's direct-to-consumer television ads, which began in 1999.

close

Next Article in Briefs

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Briefs

New Year's Countdown DMN style

New Year's Countdown DMN style

Just in case you missed any of the action, we've pulled together the top Direct Marketing News content of 2012 for you.

Making waves in B2B: Current goings-on in the marketing world

Making waves in B2B: Current goings-on in the ...

Email list prices drop as new marketing players get in the game and veteran vendors beef up their wares.